Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952-53; an additional note on Chikungunya virus isolations and serum antibodies.

Literature DB >> 13443013

An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952-53; an additional note on Chikungunya virus isolations and serum antibodies.

P J MASON, A J HADDOW.

Abstract

Entities: Disease Species

Keywords: DENGUE/epidemiology

Mesh：

Year: 1957 PMID： 13443013 DOI： 10.1016/0035-9203(57)90022-6

Source DB: PubMed Journal: Trans R Soc Trop Med Hyg ISSN： 0035-9203 Impact factor: 2.184

Keyword Cloud
Cited

× No keyword cloud information.

37 in total

1. Recent Advances in Virus Infections: The New Era in Virology.

Authors: A J Rhodes
Journal: Br Med J Date: 1960-04-09

2. Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages.

Authors: Karine Labadie; Thibaut Larcher; Christophe Joubert; Abdelkrim Mannioui; Benoit Delache; Patricia Brochard; Lydie Guigand; Laurence Dubreil; Pierre Lebon; Bernard Verrier; Xavier de Lamballerie; Andreas Suhrbier; Yan Cherel; Roger Le Grand; Pierre Roques
Journal: J Clin Invest Date: 2010-02-22 Impact factor: 14.808

Review 3. 51 years in of Chikungunya clinical vaccine development: A historical perspective.

Authors: Arturo Reyes-Sandoval
Journal: Hum Vaccin Immunother Date: 2019-04-02 Impact factor: 3.452

4. [Recent data from serological surveys on the prevalence of arbovirus infections in Africa, with special reference to yellow fever].

Authors: P Brès
Journal: Bull World Health Organ Date: 1970 Impact factor: 9.408

5. Chikungunya virus induces IPS-1-dependent innate immune activation and protein kinase R-independent translational shutoff.

Authors: Laura K White; Tina Sali; David Alvarado; Evelina Gatti; Philippe Pierre; Daniel Streblow; Victor R Defilippis
Journal: J Virol Date: 2010-10-20 Impact factor: 5.103

6. Beyond Members of the Flaviviridae Family, Sofosbuvir Also Inhibits Chikungunya Virus Replication.

Authors: André C Ferreira; Patrícia A Reis; Caroline S de Freitas; Carolina Q Sacramento; Lucas Villas Bôas Hoelz; Mônica M Bastos; Mayara Mattos; Natasha Rocha; Isaclaudia Gomes de Azevedo Quintanilha; Carolina da Silva Gouveia Pedrosa; Leticia Rocha Quintino Souza; Erick Correia Loiola; Pablo Trindade; Yasmine Rangel Vieira; Giselle Barbosa-Lima; Hugo C de Castro Faria Neto; Nubia Boechat; Stevens K Rehen; Karin Brüning; Fernando A Bozza; Patrícia T Bozza; Thiago Moreno L Souza
Journal: Antimicrob Agents Chemother Date: 2019-01-29 Impact factor: 5.191

An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952-53; an additional note on Chikungunya virus isolations and serum antibodies.

1. Recent Advances in Virus Infections: The New Era in Virology.

2. Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages.

Review 3. 51 years in of Chikungunya clinical vaccine development: A historical perspective.

4. [Recent data from serological surveys on the prevalence of arbovirus infections in Africa, with special reference to yellow fever].

5. Chikungunya virus induces IPS-1-dependent innate immune activation and protein kinase R-independent translational shutoff.

6. Beyond Members of the Flaviviridae Family, Sofosbuvir Also Inhibits Chikungunya Virus Replication.

7. Destructive arthritis in a patient with chikungunya virus infection with persistent specific IgM antibodies.

8. BHK-21 Cell Clones Differ in Chikungunya Virus Infection and MXRA8 Receptor Expression.

9. Mouse macrophage innate immune response to Chikungunya virus infection.

10. Chikungunya virus with E1-A226V mutation causing two outbreaks in 2010, Guangdong, China.